Seton Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SETON PHARM, and what generic and branded alternatives to SETON PHARM drugs are available?
SETON PHARM has five approved drugs.
Summary for Seton Pharm
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Seton Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-004 | Oct 30, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Seton Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | FOR SOLUTION;INHALATION | 206667-001 | Apr 24, 2019 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-002 | Oct 30, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Seton Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Seton Pharm | PEDIAPRED | prednisolone sodium phosphate | SOLUTION;ORAL | 019157-001 | May 28, 1986 | 4,448,774 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
